Elvucitabine acts as:
**Core Concept**
Elvucitabine is a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of HIV-1 infection. It works by inhibiting the reverse transcriptase enzyme, which is essential for the replication of retroviruses.
**Why the Correct Answer is Right**
Elvucitabine is a prodrug that is converted into its active metabolite, which then competes with natural nucleotides for incorporation into the viral DNA strand. This incorporation leads to chain termination, preventing the completion of viral DNA replication. Elvucitabine's mechanism of action is similar to other NRTIs, such as zidovudine and lamivudine.
**Why Each Wrong Option is Incorrect**
* **Option A:** Incorrect because Elvucitabine is not a protease inhibitor.
* **Option B:** Incorrect because Elvucitabine is not an integrase inhibitor.
* **Option C:** Incorrect because Elvucitabine is not a non-nucleoside reverse transcriptase inhibitor (NNRTI).
**Clinical Pearl / High-Yield Fact**
It's essential to remember that NRTIs, like Elvucitabine, can cause mitochondrial toxicity due to their mechanism of action. This can lead to side effects such as lactic acidosis and hepatotoxicity.
**Correct Answer: D. Nucleoside reverse transcriptase inhibitor (NRTI)**